StockData
McKesson Corp logo

McKesson Corp (MCK) stock

MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3027% above fair value
$1091.67−13.37 (-1.21%)

Close on Nov 17, 2026Market cap $127.28BP/E 29.2Yield 0.29%

McKesson operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

McKesson's operating cash flow for the twelve months ending Jun 30, 2026 was $6.85B, up 4.7% year over year. For fiscal 2026 it was $6.16B, up 1.2% from the year before. Over ten years it grew 5.3% a year on average. The highest annual figure on record is $6.16B in fiscal 2026.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026$6.16B+1.2%
FY2025Mar 31, 2025$6.09B+41.1%
FY2024Mar 31, 2024$4.31B-16.4%
FY2023Mar 31, 2023$5.16B+16.4%
FY2022Mar 31, 2022$4.43B-2.4%
FY2021Mar 31, 2021$4.54B+3.8%
FY2020Mar 31, 2020$4.37B+8.4%
FY2019Mar 31, 2019$4.04B-7.1%
FY2018Mar 31, 2018$4.35B-8.4%
FY2017Mar 31, 2017$4.74B+29.2%
FY2016Mar 31, 2016$3.67B+18.0%
FY2015Mar 31, 2015$3.11B-0.8%
FY2014Mar 31, 2014$3.14B+26.3%
FY2013Mar 31, 2013$2.48B-15.8%
FY2012Mar 31, 2012$2.95B+26.2%
FY2011Mar 31, 2011$2.34B+0.9%
FY2010Mar 31, 2010$2.32B+71.4%
FY2009Mar 31, 2009$1.35B+55.5%
FY2008Mar 31, 2008$869.00M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026-$220.00M–
Q4 FY2026CQ1 2026Mar 31, 2026$3.42B-55.8%
Q3 FY2026CQ4 2025Dec 31, 2025$1.23B–
Q2 FY2026CQ3 2025Sep 30, 2025$2.42B+15.2%
Q1 FY2026CQ2 2025Jun 30, 2025-$918.00M–
Q4 FY2025CQ1 2025Mar 31, 2025$7.75B+86.8%
Q3 FY2025CQ4 2024Dec 31, 2024-$2.38B-1038.2%
Q2 FY2025CQ3 2024Sep 30, 2024$2.10B+117.6%
Q1 FY2025CQ2 2024Jun 30, 2024-$1.38B–
Q4 FY2024CQ1 2024Mar 31, 2024$4.15B+24.7%
Q3 FY2024CQ4 2023Dec 31, 2023$254.00M-84.8%
Q2 FY2024CQ3 2023Sep 30, 2023$965.00M-12.8%
Q1 FY2024CQ2 2023Jun 30, 2023-$1.05B–
Q4 FY2023CQ1 2023Mar 31, 2023$3.33B+15.2%
Q3 FY2023CQ4 2022Dec 31, 2022$1.67B+21.1%
Q2 FY2023CQ3 2022Sep 30, 2022$1.11B-38.2%
Q1 FY2023CQ2 2022Jun 30, 2022-$941.00M–
Q4 FY2022CQ1 2022Mar 31, 2022$2.89B-14.3%
Q3 FY2022CQ4 2021Dec 31, 2021$1.38B+13.5%
Q2 FY2022CQ3 2021Sep 30, 2021$1.79B+75.5%
Q1 FY2022CQ2 2021Jun 30, 2021-$1.62B–
Q4 FY2021CQ1 2021Mar 31, 2021$3.37B-27.6%
Q3 FY2021CQ4 2020Dec 31, 2020$1.21B–
Q2 FY2021CQ3 2020Sep 30, 2020$1.02B–
Q1 FY2021CQ2 2020Jun 30, 2020-$1.06B–
Q4 FY2020CQ1 2020Mar 31, 2020$4.65B+19.5%
Q3 FY2020CQ4 2019Dec 31, 2019-$121.00M–
Q2 FY2020CQ3 2019Sep 30, 2019-$108.00M-107.8%
Q1 FY2020CQ2 2019Jun 30, 2019-$51.00M–
Q4 FY2019CQ1 2019Mar 31, 2019$3.90B+28.8%
Q3 FY2019CQ4 2018Dec 31, 2018-$177.00M–
Q2 FY2019CQ3 2018Sep 30, 2018$1.38B+130.6%
Q1 FY2019CQ2 2018Jun 30, 2018-$1.06B-243.2%
Q4 FY2018CQ1 2018Mar 31, 2018$3.02B+110.7%
Q3 FY2018CQ4 2017Dec 31, 2017-$18.00M-104.7%
Q2 FY2018CQ3 2017Sep 30, 2017$598.00M-44.1%
Q1 FY2018CQ2 2017Jun 30, 2017$741.00M–
Q4 FY2017CQ1 2017Mar 31, 2017$1.44B–
Q3 FY2017CQ4 2016Dec 31, 2016$381.00M–
Q2 FY2017CQ3 2016Sep 30, 2016$1.07B–

More McKesson figures

See a number that looks wrong?